英夫利昔单抗对中毒性表皮坏死松解症病程具有有益且快速的疗效。 - Suppr

Suppr

超能文献

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

作者信息

Wojtkiewicz Agnieszka, Wysocki Mariusz, Fortuna Jacek, Chrupek Małgorzata, Matczuk Maciej, Koltan Andrzej

出版信息

Acta Derm Venereol. 2008;88(4):420-1. doi: 10.2340/00015555-0462.

DOI:10.2340/00015555-0462

PMID:18709327

Abstract

摘要

相似文献

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

Acta Derm Venereol. 2008;88(4):420-1. doi: 10.2340/00015555-0462.

Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases.

J Eur Acad Dermatol Venereol. 2007 May;21(5):717-9. doi: 10.1111/j.1468-3083.2006.02026.x.

Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab.

Acta Derm Venereol. 2005;85(6):534-5. doi: 10.1080/00015550510037062.

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.

J Allergy Clin Immunol. 2005 Oct;116(4):923-4. doi: 10.1016/j.jaci.2005.06.029. Epub 2005 Aug 19.

Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.

Br J Dermatol. 2002 Apr;146(4):707-9. doi: 10.1046/j.1365-2133.2002.46833.x.

Successful treatment of childhood cutaneous polyarteritis nodosa with infliximab.

J Eur Acad Dermatol Venereol. 2007 Apr;21(4):570-1. doi: 10.1111/j.1468-3083.2006.01967.x.

Severe cutaneous adverse reactions to drugs.

Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):304-9. doi: 10.1097/ACI.0b013e328216f54a.

Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab.

Br J Dermatol. 2005 Aug;153(2):448-9. doi: 10.1111/j.1365-2133.2005.06744.x.

Treatment of toxic epidermal necrolysis with the combination of infliximab and high-dose intravenous immunoglobulin.

Dermatology. 2012;224(2):134-9. doi: 10.1159/000338202. Epub 2012 May 3.

Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.

Br J Dermatol. 2007 Oct;157(4):828-31. doi: 10.1111/j.1365-2133.2007.08111.x. Epub 2007 Aug 17.

引用本文的文献

The case for etanercept in the management of toxic epidermal necrolysis.

Skin Health Dis. 2025 May 28;5(4):247-255. doi: 10.1093/skinhd/vzaf012. eCollection 2025 Aug.

Carbamazepine-induced Stevens-Johnson Syndrome: A Case Report with Review of the Literature.

Curr Drug Saf. 2025;20(3):382-387. doi: 10.2174/0115748863328893241018101435.

Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.

Dermatol Ther (Heidelb). 2023 Jun;13(6):1305-1327. doi: 10.1007/s13555-023-00928-w. Epub 2023 May 13.

Etanercept leads to a rapid recovery of a Dabrafenib-/Trametinib-associated toxic epidermal necrolysis-like severe skin reaction.

Skin Health Dis. 2022 Nov 5;3(1):e185. doi: 10.1002/ski2.185. eCollection 2023 Feb.

Cephradine-Induced Toxic Epidermal Necrolysis: A Case Report of Treatment With Etanercept.

Cureus. 2022 Dec 18;14(12):e32657. doi: 10.7759/cureus.32657. eCollection 2022 Dec.

A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Biomedicines. 2022 Aug 28;10(9):2105. doi: 10.3390/biomedicines10092105.

Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.

Pediatric SJS-TEN: Where are we now?

F1000Res. 2020 Aug 13;9. doi: 10.12688/f1000research.20419.1. eCollection 2020.

Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

F1000Res. 2020 Jun 16;9. doi: 10.12688/f1000research.24748.1. eCollection 2020.

TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis.

Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620926800. doi: 10.1177/1753466620926800.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验